1Petri M, Jones RJ, Brodsky RA. High - dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum,2003,48:166
2Contreras GL, Pardo V, Leclercq B, et al. Sequential terapies for proliferative lupus nephritis. N Engl J Med,2004,350:971
3Balow JE, Austin HA. Maintenance therapy for lupus nephritis - something old, something new. N Engl J Med, 2004,350:1044
4Flanc RS, Roberts MA, Strippoli GF, et al. Treatment of diffuse proliferative lupus nephritis: a meta - analysis of randomized controlled trials.AmJ Kidney Dis, 2004,43:197
5Weening J J, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [ J ]. Kidney Int. 2004,65(2) :521-530.
6Austin HA 3rd, Klippel JH, Balow JE, et al. Therapy of lupus nephri- tis. Controlled trim of prednisone and cytotoxic drugs[J]. N Engl J Med, 1986,314:614-619.
8Houssiau FA,Vasconcelos C, D'Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high- dose intravenous cyclophosphamide [ J ]. Ann Rheum Dis, 2010, 69 (1) :61-64.
9Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong- Guangzhou Nephrology Study Group[J]. N Engl J Med,2000,343: 1156-1162.
10Hu W,Liu Z,Chen H,et al. Mycophenolate mofetil vs eyclophospha- mide therapy for patients with diffuse proliferative lupus nephritis F JT. Chin Med J (Engl) ,2002,115:705-709.
